BIOGYBIOGYOTC

Revenue (LTM)

$1.5B

+8.1% YoY

Net Income (LTM)

$333M

-5.3% YoY

Free Cash Flow

$303M

Revenue CAGR (5Y)

+15.5%

—Marginsstable

FCF$0.3B

Profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	785	1,104↑40.6%	1,297↑17.4%	1,423↑9.7%	1,538↑8.1%
Gross Profit	583	802↑37.6%	950↑18.5%	1,031↑8.5%	1,129↑9.5%
Operating Income	254	361↑42.5%	443↑22.6%	423↓4.5%	412↓2.6%
Net Income	196	374↑90.4%	365↓2.3%	351↓3.8%	333↓5.3%
EBITDA	277	477↑72.2%	455↓4.5%	539↑18.4%	454↓15.8%
EPS Diluted	1.94	3.70↑90.7%	3.62↓2.2%	3.48↓3.9%	3.29↓5.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	1,485	1,488↑0.2%	1,544↑3.8%	1,224↓20.7%	801↓34.5%
Total Current Assets	1,752	1,797↑2.6%	1,874↑4.3%	1,610↓14.1%	1,219↓24.3%
Total Assets	2,128	2,214↑4.0%	2,333↑5.4%	2,034↓12.8%	1,598↓21.4%
Total Current Liabilities	127	165↑30.0%	196↑18.6%	206↑5.3%	199↓3.4%
Total Liabilities	251	242↓3.6%	303↑25.4%	310↑2.4%	284↓8.5%
Total Equity	1,877	1,972↑5.1%	2,030↑2.9%	1,724↓15.1%	1,314↓23.8%
Total Debt	10	20↑93.2%	9↓56.2%	29↑235.0%	0
Net Debt	-1,474	-1,468↑0.4%	-1,544↓5.2%	-1,224↑20.7%	-801↑34.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	222	319↑43.7%	426↑33.6%	373↓12.4%	307↓17.9%
Capital Expenditure	-6	-18↓180.9%	-49↓171.9%	-14↑70.9%	-4↑74.6%
Free Cash Flow	215	301↑39.7%	377↑25.3%	359↓4.8%	303↓15.6%
Stock-Based Comp	0	0	0	0	0
Net Change in Cash	17	4↓78.1%	56↑1414.5%	-320↓673.6%	-423↓32.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance